Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06510114
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-24
Brief Title:
A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Two Intravenous Methylprednisolone Protocols in Patients With Graves Orbitopathy a Randomized Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intravenous glucocorticoid IVGC is an accessible and effective therapy for Graves orbitopathy GO the 45-g weekly protocol is well studied but many details of treatment protocols need to be clarified The goal of this trial is to compare the efficacy and safety of weekly and daily protocol of IVGC in GO Researchers will compare daily protocol to weekly protocol to see if daily protocol works to treat GO
Detailed Description:
The goal of this trial is to compare the efficacy and safety of weekly and daily protocol of IVGC in GO
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None